UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Harmony Gold Mining
HMY
$12.3B
| $528K | ﹤0.01% |
+51,945
| New | +$507K |
|
2577
Stoke Therapeutics
STOK
$2.11B
| $525K | ﹤0.01% |
42,692
-14,707
| -26% | -$208K |
|
2578
Vishay Precision Group
VPG
$914M
| $522K | ﹤0.01% |
20,149
-2,665
| -12% | -$75.8K |
|
|
SAGE
2579
DELISTED
Sage Therapeutics
SAGE
| $521K | ﹤0.01% |
72,149
-10,027
| -12% | -$91.8K |
|
2580
Nuvation Bio
NUVB
$2.32B
| $517K | ﹤0.01% |
225,619
-8,670
| -4% | -$26.4K |
|
2581
LendingTree
TREE
$451M
| $516K | ﹤0.01% |
+8,887
| New | +$459K |
|
|
DEC
2582
Diversified Energy Company
DEC
$980M
| $513K | ﹤0.01% |
45,117
-25,741
| -36% | -$346K |
|
2583
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $513K | ﹤0.01% |
+400
| New | +$490K |
|
2584
NextNav
NN
$2.23B
| $510K | ﹤0.01% |
68,080
-8,023
| -11% | -$61.9K |
|
|
LUCK
2585
Lucky Strike Entertainment
LUCK
$911M
| $509K | ﹤0.01% |
43,333
-8,838
| -17% | -$107K |
|
|
CRON
2586
Cronos Group
CRON
$1.14B
| $508K | ﹤0.01% |
231,965
-39,211
| -14% | -$89.7K |
|
2587
Universal Logistics Holdings
ULH
$529M
| $507K | ﹤0.01% |
11,768
-1,094
| -9% | -$45.3K |
|
|
FNA
2588
DELISTED
Paragon 28, Inc.
FNA
| $501K | ﹤0.01% |
75,020
-2,228
| -3% | -$16.9K |
|
2589
Titan Machinery
TITN
$445M
| $500K | ﹤0.01% |
35,868
-3,364
| -9% | -$50.4K |
|
2590
FLEX LNG
FLNG
$1.67B
| $499K | ﹤0.01% |
19,597
-5,904
| -23% | -$156K |
|
2591
Kyverna Therapeutics
KYTX
$484M
| $498K | ﹤0.01% |
101,900
-13,465
| -12% | -$104K |
|
2592
Fate Therapeutics
FATE
$326M
| $497K | ﹤0.01% |
142,131
-46,329
| -25% | -$180K |
|
2593
Greene County Bancorp
GCBC
$589M
| $493K | ﹤0.01% |
15,947
+6,517
| +69% | +$209K |
|
2594
Ranpak Holdings
PACK
$473M
| $491K | ﹤0.01% |
75,154
+13,767
| +22% | +$94.8K |
|
2595
Altimmune
ALT
$599M
| $487K | ﹤0.01% |
79,266
-25,916
| -25% | -$176K |
|
|
AVDL
2596
DELISTED
Avadel Pharmaceuticals
AVDL
| $484K | ﹤0.01% |
+36,897
| New | +$562K |
|
|
SHCO
2597
DELISTED
Soho House & Co
SHCO
| $483K | ﹤0.01% |
94,693
-6,658
| -7% | -$36.5K |
|
2598
iRadimed
IRMD
$1.18B
| $482K | ﹤0.01% |
9,585
-2,446
| -20% | -$113K |
|
|
CBL
2599
CBL Properties
CBL
$1.75B
| $473K | ﹤0.01% |
18,781
+173
| +0.9% | +$4.39K |
|
|
GTLS.PRB
2600
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $472K | ﹤0.01% |
9,400
-6,600
| -41% | -$349K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.